Although the striking variation in the frequency of the FGFR3::TACC3 fusions among different cancer types in different organs is suggestive of a potential morphomolecular correlation, to date no studies are available that critically evaluate the morphological features of FGFR3::TACC3-altered carcinomas. This evidence concerns the gene TACC3 and cancer.